SCHEMBL5558364

SCHEMBL5558364

C=C(C)Cc1cc(-c2ccccc2)ccc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.55
▸ BACE1 P56817 1/20 0.53
▸ ALOX5 P09917 1/20 0.50
▸ HSD17B1 P14061 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ ESR2 Q92731 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ APOBEC3A P31941 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1257364 0.91 GABRA1 (0.52) CYP1A2BACE1ALOX5HSD17B1ESR2
SCHEMBL19104720 0.87 GABRA1 (0.48) CYP1A2BACE1ALOX5HSD17B1ESR2
SCHEMBL20684744 0.83 APP (0.41) CYP1A2BACE1ALOX5HSD17B1ESR2
SCHEMBL12247921 0.83 HSD17B1 (0.46) CYP1A2HSD17B1ESR2GABRA1GABRB2
SCHEMBL1023129 0.78 HSD17B1 (0.66) CYP1A2BACE1ALOX5HSD17B1KDM4E
SCHEMBL50409 0.77 BACE1 (0.62) CYP1A2BACE1ALOX5HSD17B1KDM4E
SCHEMBL9716759 0.76 BACE1 (0.61) CYP1A2BACE1ALOX5HSD17B1KDM4E
SCHEMBL9446145 0.76 EGFR (0.44) CYP1A2ALDH1A1LMNAHPGDALOX15
SCHEMBL27694509 0.76 CYP1A2 (0.51) CYP1A2BACE1ALOX5HSD17B1KDM4E
SCHEMBL251843 0.75 AKR1B1 (0.56) KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351964-B1 SILANYL PHENOLS AND NAPHTHOLS CIBA SC HOLDING AG (CH) 2007-04-11 — — EP disclosed
US-7078550-B2 Silanyl phenols and naphthols CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-07-18 — — US disclosed
US-20040058891-A1 Silanyl phenols and naphthols CIBA SPECIALTY CHEMICALS CORP. 2004-03-25 — — US disclosed
EP-1351964-A2 SILANYL PHENOLS AND NAPHTHOLS Ciba SC Holding AG (CH) 2003-10-15 — — EP disclosed
WO-2002058016-A2 SILANYL PHENOLS AND NAPHTHOLS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-07-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058891-A1 Silanyl phenols and naphthols FOS, OSBP, CBR1 CYP1A2 1065/4885BACE1 4415/4885ALOX5 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback